Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Summary
This study examines the impact of proton based stereotactic radiation therapy (SBRT) on kidney function as well as other oncologic outcomes including local control, locoregional and systemic failure, progression free and overall survival.
Official title: Prospective Phase II Study of Stereotactic Body Proton Therapy for Treatment of PrimAry Renal Cell Carcinoma (SPARE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-02-25
Completion Date
2030-08
Last Updated
2026-04-03
Healthy Volunteers
No
Conditions
Interventions
Proton Stereotactic Body Radiation therapy (SBRT)
Radiation therapy will consist of 3-5 treatments over 1.5 - 2 weeks
Locations (1)
Sibley Memorial Hospital
Washington D.C., District of Columbia, United States